IP Library Granted Patent US 7,957,059
Granted Patent B2
US 7,957,059 · App. 12/046,054 · Granted Jun 7, 2011

Device and method for demonstrating optical effects

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,957,059
App. No.
12/046,054
Granted
Jun 7, 2011
Kind
B2
Abstract

An optical system includes two lens systems, one that provides viewing of an object with relatively no spherical aberration, and another that provides viewing of the object with significant spherical aberration. Preferably, both lens systems provide viewing of the object with relatively no chromatic aberration. The optical system may have the configuration of binoculars.

Claims (24)

1. An optical system comprising:

a first lens system that provides viewing of an object with relatively no spherical aberration and with relatively no chromatic aberration, the first lens system comprising an achromatic doublet lens; and

a second lens system that provides viewing of the object with significant spherical aberration and with relatively no chromatic aberration, the second lens system comprising a reversed achromatic doublet lens that imparts spherical aberration,

wherein the effect of spherical aberration and the object are magnified by the second lens system.

2. The optical system of claim 1 , wherein the first lens system includes a first telescope comprising an eyepiece lens, and the second lens system includes a second telescope comprising an eyepiece lens.

3. The optical system of claim 2 , wherein a spacing between the eyepiece lens and the achromatic doublet lens of the first telescope is smaller than a spacing between the eyepiece lens and the reversed achromatic doublet lens of the second telescope.

4. The optical system of claim 2 , wherein the first and second telescopes are connected with a housing.

5. The optical system of claim 4 , wherein the first and the second telescopes are mutually adjustable by a viewer to achieve focus of the object at a desired distance.

6. The optical system of claim 5 , wherein the eyepiece of the second telescope is adjustable, independently of the eyepiece of the first telescope.

7. The optical system of claim 2 , wherein the first and second telescopes include exit pupils with the same diameter.

8. The optical system of claim 2 , wherein the first and second telescopes have the same field of view.

9. The optical system of claim 1 , wherein the first lens system includes a first telescope comprising a first objective lens and a first eyepiece lens, and the second lens system includes a second telescope comprising a second objective lens and a second eyepiece lens, and the first telescope and the second telescope each provides view of the object with relatively no chromatic aberration.

10. The optical system of claim 9 , wherein the first objective lens comprises an achromatic doublet lens, and the second objective lens comprises a reversed achromatic doublet lens, and a spacing between the eyepiece lens and the achromatic doublet lens of the first telescope is smaller than a spacing between the eyepiece lens and the reversed achromatic doublet lens of the second telescope.

11. The optical system of claim 9 , wherein the first and second telescopes include exit pupils with the same diameter, and have the same field of view.

12. The optical system of claim 9 , wherein the first and second telescopes are connected with a housing.

13. The optical system of claim 12 , having the configuration of binoculars.

14. The optical system of claim 1 , wherein an angular extent in object space of the spherical aberration in the second lens system matches that of an average human eye.

15. A method of demonstrating the optical effect of spherical aberration to a viewer, comprising:

providing a first lens system that provides viewing of an object with relatively no spherical aberration and with relatively no chromatic aberration, and a second lens system that provides viewing of an object with significant spherical aberration and with relatively no chromatic aberration, the second lens system comprising a reversed achromatic doublet lens that imparts spherical aberration, and wherein the spherical aberration effect is magnified, along with the object, when the object is viewed by the second lens system; and

alternating viewing of an object by the viewer with only the first lens system and only the second lens system.

16. The method of claim 15 , wherein the first lens system includes a first telescope comprising a first objective lens and a first eyepiece lens, and the second lens system includes a second telescope comprising a second objective lens and a second eyepiece lens.

17. The method of claim 16 , wherein the first objective lens comprises an achromatic doublet lens, and the second objective lens comprises a reversed achromatic doublet lens, and a spacing between the eyepiece lens and the achromatic doublet lens of the first telescope is smaller than a spacing between the eyepiece lens and the reversed achromatic doublet lens of the second telescope.

18. The method of claim 16 , wherein the first and the second telescopes include exit pupils with the same diameter, and have the same field of view.

19. The method of claim 18 , wherein the first and the second telescopes are connected with a housing, and the device has the configuration of binoculars.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Aug 15, 2011
From: BAUSCH & LOMB INCORPORATED
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 026753/0554 →
SECURITY AGREEMENT Recorded May 20, 2008
From: WP PRISM INC.; BAUSCH & LOMB INCORPORATED; B & L CRL, INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; EYEONICS, INC.
To: CREDIT SUISSE
Reel/Frame 020963/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2008
From: UNSBO, JAN PETER
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 020632/0692 →